BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lang C, Yin C, Lin K, Li Y, Yang Q, Wu Z, Du H, Ren D, Dai Y, Peng X. m6 A modification of lncRNA PCAT6 promotes bone metastasis in prostate cancer through IGF2BP2-mediated IGF1R mRNA stabilization. Clin Transl Med 2021;11:e426. [PMID: 34185427 DOI: 10.1002/ctm2.426] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 10.5] [Reference Citation Analysis]
Number Citing Articles
1 Zhang L, Xia J. N6-Methyladenosine Methylation of mRNA in Cell Senescence. Cell Mol Neurobiol 2023;43:27-36. [PMID: 34767142 DOI: 10.1007/s10571-021-01168-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Chu H, Li K, Gu J, Xie W, Xie Y, Ma J. Long Non-coding RNA INE1 Induced Autophagy Promotes Sensitivity of Prostate Cancer Cells to Cisplatin. ann urol oncol 2022. [DOI: 10.32948/auo.2022.11.24] [Reference Citation Analysis]
3 Wang Z, Zhou J, Zhang H, Ge L, Li J, Wang H. RNA m(6) A methylation in cancer. Mol Oncol 2023;17:195-229. [PMID: 36260366 DOI: 10.1002/1878-0261.13326] [Reference Citation Analysis]
4 Li W, Zhou R, Sun B, Jin X, Chen Y, Xu X. Prognostic significance of lncRNA AP004608.1 in prostate cancer. Front Oncol 2022;12:1017635. [DOI: 10.3389/fonc.2022.1017635] [Reference Citation Analysis]
5 Bian Y, Wang Y, Xu S, Gao Z, Li C, Fan Z, Ding J, Wang K. m6A Modification of Long Non-Coding RNA HNF1A-AS1 Facilitates Cell Cycle Progression in Colorectal Cancer via IGF2BP2-Mediated CCND1 mRNA Stabilization. Cells 2022;11:3008. [DOI: 10.3390/cells11193008] [Reference Citation Analysis]
6 Huang J, Lu A, Liang C. Deciphering and Targeting Epigenetics in Cancer Metastasis. Cancer Metastasis - Molecular Mechanism and Clinical Therapy [Working Title] 2022. [DOI: 10.5772/intechopen.106584] [Reference Citation Analysis]
7 Fang Z, Mei W, Qu C, Lu J, Shang L, Cao F, Li F. Role of m6A writers, erasers and readers in cancer. Exp Hematol Oncol 2022;11:45. [PMID: 35945641 DOI: 10.1186/s40164-022-00298-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Cai Z, Xu H, Bai G, Hu H, Wang D, Li H, Wang Z. ELAVL1 promotes prostate cancer progression by interacting with other m6A regulators. Front Oncol 2022;12:939784. [DOI: 10.3389/fonc.2022.939784] [Reference Citation Analysis]
9 Xu D, Xu Z, Bi X, Cai J, Cao M, Zheng D, Chen L, Li P, Wang H, Wu D, Yang J, Li K. Identification and functional analysis of N6-methyladenine (m(6) A)-related lncRNA across 33 cancer types. Cancer Med 2023;12:2104-16. [PMID: 35789547 DOI: 10.1002/cam4.5001] [Reference Citation Analysis]
10 You X, Wu Y, Li Q, Sheng W, Zhou Q, Fu W. Astragalus–Scorpion Drug Pair Inhibits the Development of Prostate Cancer by Regulating GDPD4-2/PI3K/AKT/mTOR Pathway and Autophagy. Front Pharmacol 2022;13:895696. [DOI: 10.3389/fphar.2022.895696] [Reference Citation Analysis]
11 Zhao J, Xu H, Su Y, Pan J, Xie S, Xu J, Qin L. Emerging Regulatory Mechanisms of N6-Methyladenosine Modification in Cancer Metastasis. Phenomics. [DOI: 10.1007/s43657-021-00043-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Yang C, Dong Z, Ling Z, Chen Y. The crucial mechanism and therapeutic implication of RNA methylation in bone pathophysiology. Ageing Res Rev 2022;79:101641. [PMID: 35569786 DOI: 10.1016/j.arr.2022.101641] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Yin X, Lin H, Lin L, Miao L, He J, Zhuo Z. LncRNAs and CircRNAs in cancer. MedComm 2022;3. [DOI: 10.1002/mco2.141] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Sa R, Liang R, Qiu X, He Z, Liu Z, Chen L. Targeting IGF2BP2 Promotes Differentiation of Radioiodine Refractory Papillary Thyroid Cancer via Destabilizing RUNX2 mRNA. Cancers (Basel) 2022;14:1268. [PMID: 35267576 DOI: 10.3390/cancers14051268] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 López J, Añazco-Guenkova AM, Monteagudo-García Ó, Blanco S. Epigenetic and Epitranscriptomic Control in Prostate Cancer. Genes (Basel) 2022;13:378. [PMID: 35205419 DOI: 10.3390/genes13020378] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
16 Kong H, Sun J, Zhang W, Zhang H, Li H. Long intergenic non-protein coding RNA 1273 confers sorafenib resistance in hepatocellular carcinoma via regulation of methyltransferase 3. Bioengineered 2022;13:3108-21. [PMID: 35037556 DOI: 10.1080/21655979.2022.2025701] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
17 Xi X, Hu Z, Wu Q, Hu K, Cao Z, Zhou J, Liao J, Zhang Z, Hu Y, Zhong X, Bao Y. High expression of small nucleolar RNA host gene 3 predicts poor prognosis and promotes bone metastasis in prostate cancer by activating transforming growth factor-beta signaling. Bioengineered 2022;13:1895-907. [PMID: 35030969 DOI: 10.1080/21655979.2021.2020393] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
18 Mu H, Li H, Liu Y, Wang X, Mei Q, Xiang W. N6-Methyladenosine Modifications in the Female Reproductive System: Roles in Gonad Development and Diseases. Int J Biol Sci 2022;18:771-82. [PMID: 35002524 DOI: 10.7150/ijbs.66218] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
19 Jiang F, Lv Q, Hu C, Li Z, Wu H, Gao S, Wang H, Zhao Y, Shao Q. PCAT6 May Be a Whistler and Checkpoint Target for Precision Therapy in Human Cancers. Cancers (Basel) 2021;13:6101. [PMID: 34885209 DOI: 10.3390/cancers13236101] [Reference Citation Analysis]
20 Slabáková E, Kahounová Z, Procházková J, Souček K. Regulation of Neuroendocrine-like Differentiation in Prostate Cancer by Non-Coding RNAs. Noncoding RNA 2021;7:75. [PMID: 34940756 DOI: 10.3390/ncrna7040075] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Fan S, Wang L. N6-Methyladenosine-regulated LINC00675 Suppress the Proliferation, Migration and Invasion of Breast Cancer cells via Inhibiting miR-513b-5p. Bioengineered 2021. [PMID: 34738869 DOI: 10.1080/21655979.2021.2001905] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
22 Zhang Z, Wei W, Wang H, Dong J. N6-Methyladenosine-Sculpted Regulatory Landscape of Noncoding RNA. Front Oncol 2021;11:743990. [PMID: 34722298 DOI: 10.3389/fonc.2021.743990] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
23 Yan Y, Peng J, Liang Q, Ren X, Cai Y, Peng B, Chen X, Wang X, Yi Q, Xu Z. Dynamic m6A-ncRNAs association and their impact on cancer pathogenesis, immune regulation and therapeutic response. Genes & Diseases 2021. [DOI: 10.1016/j.gendis.2021.10.004] [Reference Citation Analysis]